RISK-BENEFIT RATIO IN THE TREATMENT OF PSORIASIS WITH SYSTEMIC RETINOIDS

被引：16

作者：

HALIOUA, B ^{[1
]}

SAURAT, JH ^{[1
]}

机构：

[1] UNIV GENEVA, HOP CANTONAL, DEPT DERMATOL, DERMATOL CLIN, CH-1211 GENEVA 4, SWITZERLAND

来源：

BRITISH JOURNAL OF DERMATOLOGY | 1990年 / 122卷

关键词：

D O I：

10.1111/j.1365-2133.1990.tb02891.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：135 / 150

页数：16

共 163 条

[1]

ADAMO S, 1979, J BIOL CHEM, V254, P3279

[2] SEVERE EDEMA ASSOCIATED WITH ETRETINATE [J].

ALLAN, S ;

CHRISTMAS, T .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1988, 19 (01) :140-140

[3]

ARCHER CB, 1987, LANCET, V1, P741

[4]

ARCHER CB, 1987, BRIT J DERMATOL, V12, P239

[5] ETRETINATE AND THE NAILS (STUDY OF 130 CASES) POSSIBLE MECHANISMS OF SOME SIDE-EFFECTS [J].

BARAN, R .

CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1986, 11 (02) :148-152

[6]

BARAN R, 1982, ANN DERMATOL VENER, V109, P367

[7]

BARAN R, 1983, ANN DERMATOL VENER, V10, P161

[8]

BARAN R, 1983, MED ACTUELLE, V10, P161

[9] INHIBITION OF COLLAGEN DEGRADATIVE ENZYMES BY RETINOIC ACID INVITRO [J].

BAUER, EA ;

SELTZER, JL ;

EISEN, AZ .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1982, 6 (04) :603-607

[10] TOXIC HEPATITIS DUE TO COMBINATION THERAPY WITH METHOTREXATE AND ETRETINATE IN PSORIASIS [J].

BECK, HI ;

FOGED, EK .

DERMATOLOGICA, 1983, 167 (02) :94-96

← 1 2 3 4 5 6 7 8 9 10 →